Literature DB >> 16815216

Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Leila H Choe1, Brenda G Werner, Kelvin H Lee.   

Abstract

Two-dimensional protein electrophoresis (2-DE) has undergone many technical improvements in the past 30 years, resulting in an analytical method that is unparalleled in the resolution of complex protein mixtures and capable of quantifying changes in protein expression from a wide variety of tissues and samples. The technique has been applied in many studies of neurologic disease to identify changes in spot patterns that correlate with disease. The true power of the technique emerges when it is coupled to state-of-the-art methods in mass spectrometry, which enable identification of the protein or proteins contained within a spot of interest on a 2-DE map. Investigators have successfully applied the technique to gain improved understanding of neurologic disease mechanisms in humans and in animal models and to discover biomarkers that are useful in the clinical setting. An important extension to these efforts that has not been realized thus far is the desire to profile changes in protein expression that result from therapy to help relate disease-modifying effects at the molecular level with clinical outcomes. Here we review the major advances in 2-DE methods and discuss specific examples of its application in the study of neurologic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815216      PMCID: PMC3593383          DOI: 10.1016/j.nurx.2006.05.001

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  71 in total

Review 1.  Current two-dimensional electrophoresis technology for proteomics.

Authors:  Angelika Görg; Walter Weiss; Michael J Dunn
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

2.  A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease.

Authors:  Barbara A Cottrell; Veronica Galvan; Surita Banwait; Olivia Gorostiza; Christian R Lombardo; Tristan Williams; Birgit Schilling; Alyson Peel; Bradford Gibson; Edward H Koo; Christopher D Link; Dale E Bredesen
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

3.  Evaluation of several two-dimensional gel electrophoresis techniques in cardiac proteomics.

Authors:  Zhao Bo Li; Paul W Flint; Marvin O Boluyt
Journal:  Electrophoresis       Date:  2005-09       Impact factor: 3.535

4.  Positional reproducibility of protein spots in two-dimensional polyacrylamide gel electrophoresis using immobilised pH gradient isoelectric focusing in the first dimension: an interlaboratory comparison.

Authors:  J M Corbett; M J Dunn; A Posch; A Görg
Journal:  Electrophoresis       Date:  1994 Aug-Sep       Impact factor: 3.535

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

Review 7.  Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.

Authors:  B Van Everbroeck; J Boons; P Cras
Journal:  Clin Neurol Neurosurg       Date:  2005-01-12       Impact factor: 1.876

8.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 9.  Application of proteomics technologies in the investigation of the brain.

Authors:  Michael Fountoulakis
Journal:  Mass Spectrom Rev       Date:  2004 Jul-Aug       Impact factor: 10.946

10.  Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice.

Authors:  Kelly Tilleman; Chris Van den Haute; Hugo Geerts; Fred van Leuven; Eddy L Esmans; Luc Moens
Journal:  Proteomics       Date:  2002-06       Impact factor: 3.984

View more
  4 in total

Review 1.  Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease.

Authors:  Thomas J Montine; Randall L Woltjer; Catherine Pan; Kathleen S Montine; Jing Zhang
Journal:  NeuroRx       Date:  2006-07

2.  Microarray methods for protein biomarker detection.

Authors:  Hye Jin Lee; Alastair W Wark; Robert M Corn
Journal:  Analyst       Date:  2008-06-05       Impact factor: 4.616

3.  Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.

Authors:  Yashu Liu; Jintang He; Chen Li; Ricardo Benitez; Sherry Fu; Jorge Marrero; David M Lubman
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

4.  Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium.

Authors:  Timothy R Mhyre; Rebekah Loy; Pierre N Tariot; Louis A Profenno; Kathleen A Maguire-Zeiss; Dabao Zhang; Paul D Coleman; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2007-05-22       Impact factor: 4.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.